Sodium-glucose cotransporter 2 inhibition prevents renal fibrosis in cyclosporine nephropathy

AIMS: Sodium-glucose cotransporter 2 (SGLT2) inhibitors, a new class of antidiabetic drugs, are nephroprotective in case of diabetes, but whether a similar beneficial effect may be detectable also in case of chronic non-diabetic kidney diseases remains still unknown. The aim of this study was to eva...

Descripción completa

Detalles Bibliográficos
Autores principales: Castoldi, Giovanna, Carletti, Raffaella, Ippolito, Silvia, Colzani, Massimiliano, Barzaghi, Francesca, Stella, Andrea, Zerbini, Gianpaolo, Perseghin, Gianluca, Zatti, Giovanni, di Gioia, Cira R. T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Milan 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8272713/
https://www.ncbi.nlm.nih.gov/pubmed/33760995
http://dx.doi.org/10.1007/s00592-021-01681-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8272713/
https://www.ncbi.nlm.nih.gov/pubmed/33760995
http://dx.doi.org/10.1007/s00592-021-01681-2

Ejemplares similares